AddLife AB (ALIF B) NPV B

Sell:149.20 SEKBuy:149.90 SEK0.70 SEK (0.47%)

Prices delayed by at least 15 minutes
Sell:149.20 SEK
Buy:149.90 SEK
Change:0.70 SEK (0.47%)
Prices delayed by at least 15 minutes
Sell:149.20 SEK
Buy:149.90 SEK
Change:0.70 SEK (0.47%)
Prices delayed by at least 15 minutes

Company Information

About this company

AddLife AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The Company operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The Company operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.

Key people

Fredrik Dalborg
President, Chief Executive Officer
Christina Rubenhag
Chief Financial Officer
Peter Simonsbacka
Chief Commercial Officer
Johan Sjoe
Independent Chairman of the Board
Stefan Hedelius
Director
Hakan Roos
Director
Eva Elmstedt
Independent Director
Eva Nilsagard
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    Sweden
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    SE0014401378
  • Market cap
    SEK 17.72bn
  • Employees
    2,356
  • Shares in issue
    117.84m
  • Exchange
    Stockholm Stock Exchange
  • Index
    SX All Share PI Market Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.